 ?您的位置：對照品 > 對照品 > 自制對照品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：L177393 |
| 產(chǎn)品名稱：Lanatoside B |
| 產(chǎn)品CAS：17575-21-2 |
| 規(guī)格含量：5mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
L177393 |
| 名稱: |
Lanatoside B |
| 別名: |
(3β,5β,16β)-3-[(O-β-D-Glucopyranosyl-(1→4)-O-3-O-acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide; Digilanide B; NSC 7535; |
| CAS號: |
17575-21-2 |
| 分子式: |
C??H??O?? |
| 分子量: |
985.12 |
| 種類: |
Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
Lanatoside B is a novel cardiac glycoside inhibitor acting on sodium-potassium ATPase in vivo. |
| 參考文獻 |
|
|
|
|
|
|
